Item
Approval for Covaxin Trials Phase ||
Title (Dublin Core)
Approval for Covaxin Trials Phase ||
Description (Dublin Core)
An Indian-Based Bharat Biotech gets the regulatory approval to advance COVID-19 vaccine, Covaxine. After conducting trails on 375 volunteers at 12 different sites, The Drug Controller General of India (DCGI) gave a thumbs up to Bharat Biotech into conducting phase || trials.
Date (Dublin Core)
Creator (Dublin Core)
Contributor (Dublin Core)
Event Identifier (Dublin Core)
Partner (Dublin Core)
Type (Dublin Core)
Text
Link (Bibliographic Ontology)
Controlled Vocabulary (Dublin Core)
Curator's Tags (Omeka Classic)
Collection (Dublin Core)
English
Healthcare
English
Vaccine Stories
Date Submitted (Dublin Core)
10/10/2020
Date Modified (Dublin Core)
10/24/2020
1/28/2021
03/15/2021
Date Created (Dublin Core)
09/07/2020
This item was submitted on October 10, 2020 by Pushan Kochar using the form “Share Your Story” on the site “A Journal of the Plague Year”: https://covid-19archive.org/s/archive
Click here to view the collected data.